4592

SanBio
4592

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
¥248.45B
EV
¥246.28B
Shares Outstanding
72.08M
Beta
-0.02

Wall Street View

Analyst Rating
UNDERPERFORM
Analyst Target Price
¥1460.00
P/E 2026E
-
P/Revenue 2026E
163.41x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About SanBio Company Limited

gainify
4592

SanBio Company Limited

4592

SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipelin...

Sector

Healthcare

Industry

Biotechnology

CEO

Mori, Keita

Employees

29

IPO Date

2015-04-08

Headquarters

St. Luke Tower, 13th Floor, 8-1 Akashi-cho, Chuo-ku, Tokyo 104-0044, Japan

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.